2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-phenyl-

Details

Top
Internal ID 020fe7fc-0079-48bc-9b07-b2e36f1093fc
Taxonomy Phenylpropanoids and polyketides > Linear 1,3-diarylpropanoids > Chalcones and dihydrochalcones > 2-Hydroxychalcones
IUPAC Name 1-(2,4-dihydroxyphenyl)-3-phenylprop-2-en-1-one
SMILES (Canonical) C1=CC=C(C=C1)C=CC(=O)C2=C(C=C(C=C2)O)O
SMILES (Isomeric) C1=CC=C(C=C1)C=CC(=O)C2=C(C=C(C=C2)O)O
InChI InChI=1S/C15H12O3/c16-12-7-8-13(15(18)10-12)14(17)9-6-11-4-2-1-3-5-11/h1-10,16,18H
InChI Key JUMSUVHHUVPSOY-UHFFFAOYSA-N
Popularity 38 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H12O3
Molecular Weight 240.25 g/mol
Exact Mass 240.078644241 g/mol
Topological Polar Surface Area (TPSA) 57.50 Ų
XlogP 3.50
Atomic LogP (AlogP) 2.99
H-Bond Acceptor 3
H-Bond Donor 2
Rotatable Bonds 3

Synonyms

Top
2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-phenyl-
4',6'-dihydroxychalcone
SCHEMBL127341
DTXSID90892375
2',4'-DHC
PD028976
D94576

2D Structure

Top
2D Structure of 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-phenyl-

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9944 99.44%
Caco-2 + 0.8183 81.83%
Blood Brain Barrier - 0.7750 77.50%
Human oral bioavailability + 0.5143 51.43%
Subcellular localzation Mitochondria 0.7898 78.98%
OATP2B1 inhibitior - 0.7204 72.04%
OATP1B1 inhibitior + 0.9353 93.53%
OATP1B3 inhibitior + 0.9441 94.41%
MATE1 inhibitior - 0.7800 78.00%
OCT2 inhibitior - 0.9588 95.88%
BSEP inhibitior - 0.6903 69.03%
P-glycoprotein inhibitior - 0.9385 93.85%
P-glycoprotein substrate - 0.9582 95.82%
CYP3A4 substrate - 0.6934 69.34%
CYP2C9 substrate - 0.6211 62.11%
CYP2D6 substrate - 0.8534 85.34%
CYP3A4 inhibition + 0.6091 60.91%
CYP2C9 inhibition + 0.8602 86.02%
CYP2C19 inhibition + 0.9374 93.74%
CYP2D6 inhibition - 0.8956 89.56%
CYP1A2 inhibition + 0.8965 89.65%
CYP2C8 inhibition + 0.7502 75.02%
CYP inhibitory promiscuity + 0.8688 86.88%
UGT catelyzed + 1.0000 100.00%
Carcinogenicity (binary) - 0.7472 74.72%
Carcinogenicity (trinary) Non-required 0.6807 68.07%
Eye corrosion - 0.9646 96.46%
Eye irritation + 0.9941 99.41%
Skin irritation + 0.8012 80.12%
Skin corrosion - 0.8765 87.65%
Ames mutagenesis - 0.5400 54.00%
Human Ether-a-go-go-Related Gene inhibition - 0.8129 81.29%
Micronuclear + 0.6400 64.00%
Hepatotoxicity - 0.7467 74.67%
skin sensitisation + 0.9341 93.41%
Respiratory toxicity - 0.7000 70.00%
Reproductive toxicity + 0.5778 57.78%
Mitochondrial toxicity - 0.7750 77.50%
Nephrotoxicity - 0.6956 69.56%
Acute Oral Toxicity (c) III 0.5832 58.32%
Estrogen receptor binding + 0.9376 93.76%
Androgen receptor binding + 0.9175 91.75%
Thyroid receptor binding + 0.6013 60.13%
Glucocorticoid receptor binding + 0.8254 82.54%
Aromatase binding + 0.9108 91.08%
PPAR gamma + 0.8903 89.03%
Honey bee toxicity - 0.9162 91.62%
Biodegradation - 0.7750 77.50%
Crustacea aquatic toxicity - 0.6600 66.00%
Fish aquatic toxicity + 0.9878 98.78%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 97.00% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 93.91% 95.56%
CHEMBL1293249 Q13887 Kruppel-like factor 5 93.25% 86.33%
CHEMBL3194 P02766 Transthyretin 91.85% 90.71%
CHEMBL2035 P08912 Muscarinic acetylcholine receptor M5 91.34% 94.62%
CHEMBL2581 P07339 Cathepsin D 88.33% 98.95%
CHEMBL3091268 Q92753 Nuclear receptor ROR-beta 87.68% 95.50%
CHEMBL2288 Q13526 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 86.60% 91.71%
CHEMBL2568 P06737 Liver glycogen phosphorylase 83.98% 96.92%
CHEMBL2535 P11166 Glucose transporter 82.54% 98.75%
CHEMBL4208 P20618 Proteasome component C5 81.17% 90.00%
CHEMBL3192 Q9BY41 Histone deacetylase 8 81.01% 93.99%

Cross-Links

Top
PubChem 344530
NPASS NPC43143
LOTUS LTS0015034
wikiData Q105203148